Novo Nordisk A/S (NVO): A Bull Case Theory
We came across a bullish thesis on Novo Nordisk A/S on r/Valueinvesting by Quorum_Ataraxia. In this article, we will summarize the bulls’ thesis on NVO.
Novo Nordisk A S (NVO)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sivik Global Healthcare Krishen Sud | 75,000 | $3,816 | 1.11% | |
| 2. | Hourglass Capital Kenneth A. Moffet | 0 | $0 | 0% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,911,891 | $249,917,014 | 0.04% | |
| 2. | Imc-chicago, LlcCALL | 2,388,600 | $121,531,968 | 0.04% |
| 3. | 2,206,819 | $112,529,610 | 0.6% | |
| 4. | Ubs Group AgPUT | 1,767,400 | $89,925,312 | 0.01% |
| 5. | 1,468,700 | $74,727,456 | 0.03% |
News See All
Jim Cramer Shared His Thoughts on These 16 Stocks
Markets can be capricious. Markets can be moronic. But if you own stocks, the market's always right. There's no alternate universe.
BMO Raises Novo Nordisk A/S (NVO) Price Target but Flags Prescription Pressures
Novo Nordisk A/S (NYSE:NVO) is among the most profitable healthcare stocks to buy.
10 Most Profitable Healthcare Stocks to Buy
By far, the healthcare sector remains among the most resilient and profitable in global equity markets.
Jim Cramer Talked About These 16 Stocks and Market Froth
Tonight, we are going to talk about something I despise.
Novo Nordisk (NVO) is "in a Battle," Says Jim Cramer
Pharma giant Novo Nordisk A/S (NYSE:NVO) created quite the buzz last month after its weight loss pill secured approval from the Food and Drug Administration (FDA), following which the shares jumped by...
10 Stocks Jim Cramer Talked About
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the impact of the Justice Department serving the Federal Reserve with grand jury subpoenas and threatening criminal indictment...
Fundsmith Equity Fund’s Thoughts on Novo Nordisk (NVO)
Fundsmith, an investment management firm based in London, has released its annual 2025 investor letter for its “Fundsmith Equity Fund.” A copy of the letter can be downloaded here.
Here’s Why SGA U.S. Large Cap Growth Strategy Sold Novo Nordisk (NVO)
Sustainable Growth Advisers (SGA), an investment management company, released its third-quarter investor letter for its “U.S.
Jim Cramer Shares Key Caveat For Novo Nordisk (NVO)'s Weight Loss Pill
Danish pharmaceutical firm Novo Nordisk A/S (NYSE:NVO) scored a major win earlier this month after it secured the Food and Drug Administration’s (FDA) approval for its weight loss pill.
Hedge Fund Resource Center Billionaire Hedge Funds
